BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 26855080)

  • 1. G4 DNA in ras genes and its potential in cancer therapy.
    Cogoi S; Xodo LE
    Biochim Biophys Acta; 2016 Apr; 1859(4):663-74. PubMed ID: 26855080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An RNA G-quadruplex in the 5' UTR of the NRAS proto-oncogene modulates translation.
    Kumari S; Bugaut A; Huppert JL; Balasubramanian S
    Nat Chem Biol; 2007 Apr; 3(4):218-21. PubMed ID: 17322877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA G-Quadruplexes in Kirsten Ras (KRAS) Oncogene as Targets for Small Molecules Inhibiting Translation.
    Miglietta G; Cogoi S; Marinello J; Capranico G; Tikhomirov AS; Shchekotikhin A; Xodo LE
    J Med Chem; 2017 Dec; 60(23):9448-9461. PubMed ID: 29140695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein hnRNPA1 binds to a critical G-rich element of KRAS and unwinds G-quadruplex structures: implications in transcription.
    Xodo L; Paramasivam M; Membrino A; Cogoi S
    Nucleic Acids Symp Ser (Oxf); 2008; (52):159-60. PubMed ID: 18776302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Position and stability are determining factors for translation repression by an RNA G-quadruplex-forming sequence within the 5' UTR of the NRAS proto-oncogene.
    Kumari S; Bugaut A; Balasubramanian S
    Biochemistry; 2008 Dec; 47(48):12664-9. PubMed ID: 18991403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical role of hnRNP A1 in activating KRAS transcription in pancreatic cancer cells: A molecular mechanism involving G4 DNA.
    Cogoi S; Rapozzi V; Cauci S; Xodo LE
    Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1389-1398. PubMed ID: 27888145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating the NRAS 5' UTR as a target for small molecules.
    Balaratnam S; Torrey ZR; Calabrese DR; Banco MT; Yazdani K; Liang X; Fullenkamp CR; Seshadri S; Holewinski RJ; Andresson T; Ferré-D'Amaré AR; Incarnato D; Schneekloth JS
    Cell Chem Biol; 2023 Jun; 30(6):643-657.e8. PubMed ID: 37257453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of a new G-quadruplex forming region within the kRAS promoter as a transcriptional regulator.
    Morgan RK; Batra H; Gaerig VC; Hockings J; Brooks TA
    Biochim Biophys Acta; 2016 Feb; 1859(2):235-45. PubMed ID: 26597160
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Marquevielle J; Kumar MVV; Mergny JL; Salgado GF
    Biomol NMR Assign; 2018 Apr; 12(1):123-127. PubMed ID: 29189986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G4-DNA formation in the HRAS promoter and rational design of decoy oligonucleotides for cancer therapy.
    Membrino A; Cogoi S; Pedersen EB; Xodo LE
    PLoS One; 2011; 6(9):e24421. PubMed ID: 21931711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The regulatory G4 motif of the Kirsten ras (KRAS) gene is sensitive to guanine oxidation: implications on transcription.
    Cogoi S; Ferino A; Miglietta G; Pedersen EB; Xodo LE
    Nucleic Acids Res; 2018 Jan; 46(2):661-676. PubMed ID: 29165690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of two G-quadruplexes in equilibrium in the KRAS promoter.
    Marquevielle J; Robert C; Lagrabette O; Wahid M; Bourdoncle A; Xodo LE; Mergny JL; Salgado GF
    Nucleic Acids Res; 2020 Sep; 48(16):9336-9345. PubMed ID: 32432667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The biological functions of G-quadruplex].
    Chen Z; Xiu MH; Li SF; Xu M
    Sheng Li Ke Xue Jin Zhan; 2010 Oct; 41(5):329-34. PubMed ID: 21416921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HRAS is silenced by two neighboring G-quadruplexes and activated by MAZ, a zinc-finger transcription factor with DNA unfolding property.
    Cogoi S; Shchekotikhin AE; Xodo LE
    Nucleic Acids Res; 2014 Jul; 42(13):8379-88. PubMed ID: 25013182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-resolution three-dimensional NMR structure of the
    Kerkour A; Marquevielle J; Ivashchenko S; Yatsunyk LA; Mergny JL; Salgado GF
    J Biol Chem; 2017 May; 292(19):8082-8091. PubMed ID: 28330874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indoloquinoline-Mediated Targeted Downregulation of KRAS through Selective Stabilization of the Mid-Promoter G-Quadruplex Structure.
    Psaras AM; Carty RK; Miller JT; Tumey LN; Brooks TA
    Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011352
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    D'Aria F; Pagano B; Petraccone L; Giancola C
    Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33466280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High resolution crystal structure of a KRAS promoter G-quadruplex reveals a dimer with extensive poly-A π-stacking interactions for small-molecule recognition.
    Ou A; Schmidberger JW; Wilson KA; Evans CW; Hargreaves JA; Grigg M; O'Mara ML; Iyer KS; Bond CS; Smith NM
    Nucleic Acids Res; 2020 Jun; 48(10):5766-5776. PubMed ID: 32313953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human MYC G-quadruplex: From discovery to a cancer therapeutic target.
    Wang W; Hu S; Gu Y; Yan Y; Stovall DB; Li D; Sui G
    Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188410. PubMed ID: 32827579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural polymorphism within a regulatory element of the human KRAS promoter: formation of G4-DNA recognized by nuclear proteins.
    Cogoi S; Paramasivam M; Spolaore B; Xodo LE
    Nucleic Acids Res; 2008 Jun; 36(11):3765-80. PubMed ID: 18490377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.